The role will be responsible for independent drug monitoring for assigned studies, including end-to-end ownership from setup to closure.
Base: $93,100.00 - $232,800.00; Bonus/Equity: Incentive plans, bonuses may be offered; Benefits: Range of health and welfare and/or other benefits
Must-have
Nice-to-have
Not specified